Results Show Potent Antiviral Efficacy of Once Daily 150 mg TMC435 in Hepatitis C Patients Who Have Failed Earlier Treatment, Especially in Prior Null Responders, and Excellent Safety and Tolerability

Oracle’s Complete, Integrated Storage Portfolio Helps Enable Customers to Lower IT Cost, Accelerate Performance

Latest Pre-Tested Configurations Include Oracle Linux Running on Oracle Systems – Program Continues to Enable Faster Time to Market, Mitigated Risk and Lower Cost

Redwood Shores, Calif. – March 31, 2011News Facts ICON (www.iconplc.com/) plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has selected the Oracle Health Sciences LabPas solution, delivered via the Oracle Health Sciences Cloud, to support subject recruitment, data capture and analysis, and enhance clinical workflows for its Phase I clinical trials.